Read + Share
Amedeo Smart
Independent Medical Education
Peplinski RM, Riordan JD, Schillo JL, Hannan EC, et al. Co-targeting the PI3K-Akt pathway improves response to MEK inhibition in low-grade serous ovarian cancer cell lines. Gynecol Oncol 2025;204:194-201.PMID: 41351945
Email
LinkedIn
Privacy Policy